World's Best Scientists 2026 revealed!
Philip J. Rosenfeld

Philip J. Rosenfeld

D-Index & Metrics

Medicine

D-Index
99
Citations
47814
World Ranking
8450
National Ranking
4368

Philip J. Rosenfeld publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Philip J. Rosenfeld sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 529 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Philip J. Rosenfeld D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Philip J. Rosenfeld sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Philip J. Rosenfeld is affiliated with the University of Miami in the United States. Their research primarily focuses on the field of Medicine, with an emphasis on Ophthalmology, Radiology, Nuclear Medicine and Imaging, as well as Molecular Biology. Additional areas of study include Pulmonary and Respiratory Medicine and Epidemiology.

The main research topics explored by Rosenfeld cover a broad spectrum of retinal and ocular health issues. These topics include:

  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Retinal and Optic Conditions
  • Glaucoma and retinal disorders
  • Ocular Diseases and Behçet's Syndrome
  • Retinal Development and Disorders
  • Retinal and Macular Surgery

Rosenfeld has frequently published in specialized venues related to ophthalmology and eye research. Notable publication venues include:

  • American Journal of Ophthalmology
  • Ophthalmology Retina
  • Ophthalmology Science
  • Investigative Ophthalmology & Visual Science
  • American Journal of Ophthalmology Case Reports

Their recent scholarly papers cover significant clinical and imaging topics in ophthalmology. These include:

  • Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials (2023), published in The Lancet
  • Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression (2022), published in JAMA Ophthalmology
  • Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration (2020), published in Ophthalmology Retina
  • Guidelines for Imaging the Choriocapillaris Using OCT Angiography (2020), published in American Journal of Ophthalmology
  • Quantification of Choriocapillaris with Phansalkar Local Thresholding: Pitfalls to Avoid (2020), published in American Journal of Ophthalmology

Rosenfeld collaborates with several frequent coauthors in their research endeavors. These include:

  • Giovanni Gregori
  • Mengxi Shen
  • Ruikang K. Wang
  • Yingying Shi
  • Omer Trivizki

Best Publications

  • Ranibizumab for Neovascular Age-Related Macular Degeneration

    Philip J. Rosenfeld;David M. Brown;Jeffrey S. Heier;David S. Boyer

  • Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies

    Steven D. Schwartz;Carl D. Regillo;Byron L. Lam;Dean Eliott

  • Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

    Philip J Rosenfeld;Andrew A Moshfeghi;Carmen A Puliafito

  • An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.

    Anne E. Fung;Geeta A. Lalwani;Philip J. Rosenfeld;Sander R. Dubovy

  • A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication

    Katherine A. Jones;James T. Kadonaga;Philip J. Rosenfeld;Thomas J. Kelly

  • A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.

    Geeta A. Lalwani;Philip J. Rosenfeld;Anne E. Fung;Sander R. Dubovy

  • Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial

    Emily Y. Chew;Traci E. Clemons;John Paul SanGiovanni;Ronald Danis

  • Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications.

    Amir H. Kashani;Chieh-Li Chen;Jin Kyu Gahm;Fang Zheng

  • Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Week Results of an Uncontrolled Open-Label Clinical Study

    Stephan Michels;Philip J. Rosenfeld;Carmen A. Puliafito;Erin N. Marcus

  • The international intravitreal bevacizumab safety survey: using the internet to assess drug safety worldwide

    A.E. Fung;P.J. Rosenfeld;E. Reichel

  • Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Macular Edema From Central Retinal Vein Occlusion

    Philip J Rosenfeld;Anne E Fung;Carmen A Puliafito

  • Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Ryan M. Rich;Philip J. Rosenfeld;Carmen A. Puliafito;Sander R. Dubovy

  • Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3.

    Srinivas R. Sadda;Robyn Guymer;Frank G. Holz;Steffen Schmitz-Valckenberg

  • Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group

    Richard F. Spaide;Glenn J. Jaffe;David Sarraf;K. Bailey Freund

  • Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin - 1-year results of a randomized clinical trial - VIP report no. 1

    J. Arnold;D. Kilmartin;J. Olson;S. Neville

  • Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.

    Jeffrey S. Heier;Andrew N. Antoszyk;Peter Reed Pavan;Steven R. Leff

  • A Null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa

    Philip J. Rosenfeld;Glenn S. Cowley;Terri L. McGee;Michael A. Sandberg

  • Novel method for analyzing snellen visual acuity measurements.

    Ninel Z Gregori;William Feuer;Philip J Rosenfeld

  • Predicted Biological Activity of Intravitreal VEGF TRAP

    Michael W Stewart;Philip J Rosenfeld

  • Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy.

    Roy H. Loo;Ingrid U. Scott;Harry W. Flynn;J. Donald M. Gass

Frequent Co-Authors

William J. Feuer
William J. Feuer University of Miami
Carmen A. Puliafito
Carmen A. Puliafito University of Southern California
Ruikang K. Wang
Ruikang K. Wang University of Washington
Harry W. Flynn
Harry W. Flynn University of Miami
Srinivas R. Sadda
Srinivas R. Sadda University of California, Los Angeles
Janet L. Davis
Janet L. Davis University of Miami
William E. Smiddy
William E. Smiddy University of Miami
Jay S. Duker
Jay S. Duker Tufts Medical Center
Emily Y. Chew
Emily Y. Chew National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in Medicine extends far beyond becoming a physician. Those considering medical studies in the USA can also pursue related healthcare degrees and rewarding career pathways online. The healthcare administration degree is ideal for students interested in leadership and management roles within healthcare organizations, clinics, and hospitals.

Registered nurses looking to advance their skills can enroll in adn to fnp programs to become Family Nurse Practitioners. These bridge programs offer accelerated pathways to higher qualifications and greater responsibilities in patient care.

For those fascinated by nutrition and wellness, there are many best online nutrition programs available, providing in-depth knowledge and preparing graduates for fast-growing roles in healthcare and lifestyle counseling.

Aspiring healthcare executives can review options on the cahme accredited online mha programs list. These programs ensure a quality education and open doors to high-level administrative careers.

Best Scientists Citing Philip J. Rosenfeld

Trending Scientists

Recently Published Articles